Image-Guided Therapy

PROCEDURE2 trials

Sponsors

M.D. Anderson Cancer Center, Mayo Clinic

Conditions

Biochemically Recurrent Prostate CarcinomaCastration-resistant Prostate CancerMalignant Liver NeoplasmRecurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate Cancer

Phase 2

Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study

Active, not recruitingNCT04083378

M.D. Anderson Cancer CenterMalignant Liver Neoplasm

Start: 2020-01-10End: 2026-10-31Updated: 2026-03-23

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

RecruitingNCT06378866

Mayo ClinicBiochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, Recurrent Castration-Sensitive Prostate Carcinoma +1

Start: 2024-06-03End: 2029-05-31Target: 532Updated: 2025-12-26

Related Papers

Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial.

2025-03-1322 citations

Study Protocol COVER-ALL: Clinical Impact of a Volumetric Image Method for Confirming Tumour Coverage with Ablation on Patients with Malignant Liver Lesions.

2022-09-0418 citations